Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

PERRIGO R AND D

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 39
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

PAI HOLDINGS PHARM

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 35
  • 0 comments

FDA approve VANCOMYCIN HYDROCHLORIDE

Comment Full text

L PERRIGO CO

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 48
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

IPSEN INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 39
  • 0 comments

FDA approve MECASERMIN RECOMBINANT

Comment Full text

L PERRIGO CO

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 40
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

TAKEDA PHARMS USA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 35
  • 0 comments

FDA approve VEDOLIZUMAB

Comment Full text

L PERRIGO CO

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 41
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

PERRIGO R AND D

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 40
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

RB HLTH

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 33
  • 0 comments

FDA approve DEXTROMETHORPHAN POLISTIREX

Comment Full text

MADRIGAL PHARMACEUTICALS INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 37
  • 0 comments

FDA approve RESMETIROM

Comment Full text
  • Previous
  • 508
  • 509
  • 510
  • 511
  • 512
  • Next

Search

News categories

  • Technical Exchange News(13024)
  • Event(6229)
  • SEC News(322729)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(181761)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin